DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer|HER2-positive Breast Cancer|Brain Metastases|Leptomeningeal Metastasis
Interventions: DRUG: Trastuzumab deruxtecan
Sponsor: MedSIR
Collaborators: Daiichi Sankyo